Crossmark

Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial

Crossref DOI link: https://doi.org/10.1186/s12891-021-04706-7

Published Online: 2021-09-24

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dório, Murillo

Pereira, Rosa Maria Rodrigues

Luz, Alexandre Galeno Branco

Deveza, Leticia Alle

de Oliveira, Ricardo Manoel

Fuller, Ricardo
License Information

Text and Data Mining valid from 2021-09-24

Version of Record valid from 2021-09-24
More Information

Article History

Received: 11 May 2021

Accepted: 10 August 2021

First Online: 24 September 2021

Declarations

:

: This study was approved by the ethics committee of the Hospital das Clínicas of the University of São Paulo: Comissão de Ética para Análise de Projetos de Pesquisa (CAPPesq), with registration number 15059, approved on 08/06/2016. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. All participants were instructed about the procedure and method of the study and signed an informed consent form.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below